Dominance of Offline Retail Shapes Expansion of the Indian Pen Needle Market

Indian pen needle market was valued at $105.8 million in 2024 and is projected to reach approximately $372.0 million by 2035, growing at a CAGR of 12.2% during the forecast period (2025–2035). The largest mode of purchase-based segment of the Indian pen needle market is retail (offline). The market is generally segmented as retail and non-retail modes, with retail purchases largely leading to the growth of the market owing to widespread accessibility through pharmacies and healthcare providers. It is mainly sold through offline channels of retail like pharmacies, clinics, and conventional medical outlets, which are important to rural consumers and diverse healthcare availability.  

Browse the full report description of “Indian Pen Needle Market Size, Share & Trends Analysis Report by Product Type (Standard Pen Needles, and Safety Pen Needles), by Therapy (Insulin Therapy, GLP-1 Therapy, Osteoporosis, Growth Hormones), and by Mode of Purchase (Online, and Offline), Forecast Period (2025-2035)” at https://www.omrglobal.com/industry-reports/indian-pen-needle-market

Face-to-face interactions and instant availability of the product lead to consumer behavior that trusts the purchase process. Offline retail plays a major role in market expansion, accounting for a larger revenue share than online channels. Digital adoption is also picking up steam, with mobile payments and inventory management becoming standard in pharmacies and stores. Moreover, pharmacies and clinics are the primary players in the offline retail market, especially in rural India, primarily due to their ability to drive bulk sales and repeat purchases.

The following are some launches of pen needles in India, with special emphasis on offline availability-

Hindustan Syringes & Medical Devices (HMD) - Dispovan Insulin Pen Needle

• India's first made-in-India pen needle is designed to be comfortable and affordable to diabetes patients.
• Locally manufactured and sold extensively in offline retail channels.
• Ergonomic shape, extra-thin wall, and multi-bevel tapered point for reduced pain during injection.

Roche Diabetes Care India - ACCU-FINE Pen Needles

• Rolled out to offer nearly painless insulin injection.
• Pack of 100 with thin wall, special coating, and gentle insertion technology.
• Made available widely in pharmacies offline throughout India.

Market Coverage

• The market number available for – 2024-2035

• Base year- 2024

• Forecast period- 2025-2035

• Segment Covered- 

o By Product Type 

o By Therapy

o By Mode of Purchase

• Competitive Landscape - B. Braun SE, Becton, Dickinson, and Co. (BD), Hindustan Syringes & Medical Devices Ltd., Novo Nordisk A/S, and Terumo Corp., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Indian Pen Needle Market Report Segment

By Product Type 

• Standard Pen Needles
• Safety Pen Needles

By Therapy

• Insulin Therapy
• GLP-1 Therapy
• Osteoporosis
• Growth Hormones

By Mode of Purchase

• Online
• Offline

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/indian-pen-needle-market